50% of prescriptions don’t work as expected. That means that every second prescription you get is either not going to work or is going to result in something bad happening to you. No surprise that adverse drug reactions are consistently a top 5 cause of death in every developed country. It is a $130b problem in the US alone. GenXys is a software company which specializes in precision prescribing software including pharmacogenetics. Our software, called TreatGx, presents individuals and their healthcare professionals with the optimum medications based on all the variables required for making an accurate prescription. TreatGx is in the Canadian market in partnership with LifeLabs, Canada’s leading national lab company. We sell to employers, benefit providers, and healthcare organizations to increase patient safety, improve population health, and significantly reduce healthcare costs. Our vision is to have every prescription, globally, powered by our software. Following our launch int...
50% of prescriptions don’t work as expected. That means that every second prescription you get is either not going to work or is going to result in something bad happening to you. No surprise that adverse drug reactions are consistently a top 5 cause of death in every developed country. It is a $130b problem in the US alone. GenXys is a software company which specializes in precision prescribing software including pharmacogenetics. Our software, called TreatGx, presents individuals and their healthcare professionals with the optimum medications based on all the variables required for making an accurate prescription. TreatGx is in the Canadian market in partnership with LifeLabs, Canada’s leading national lab company. We sell to employers, benefit providers, and healthcare organizations to increase patient safety, improve population health, and significantly reduce healthcare costs. Our vision is to have every prescription, globally, powered by our software. Following our launch into the US in late 2019, we now have 3 early adopter customers.
We license our software to genetic labs who want to provide pharmacogenetic information to their customers in a clinically useable way, to health networks to reduce financial costs and improve the quality of care, to payers who also want to reduce financial costs and improve the quality of care, and to pharmacy benefits management firms who want to maximize their top line and win new and retain new customers.
More information

Employees

Karl Pringle
Admin
Karl Pringle CEO I am an experienced leader with a track record of transforming software companies and products into brand leaders in their chosen markets.